DTC genetic testing
Nucleus Genomics Raises $14M in Series A Financing
The firm aims to use the new funding to launch heritable disease and personalized drug metabolism genetic tests.
International Consensus Statement Says Microbiome-Based Diagnostic Tests Not Ready for Prime Time
Researchers laid out a set of ethical, organizational, and technical guidelines for the development, commercial use, and clinical implementation of microbiome tests.
NowPatient Inks Pharmacogenomics Testing Deals with Aura Genetics, Zotz Klimas
Through the collaborations, UK-based NowPatient will expand its services to pharmacogenomic testing.
The Tennessee-based firm is combining molecular and protein testing technologies that it brought under one roof in a pair of deals last summer.
Direct-to-consumer microbiome tests often go beyond what the research can support, but the large databases being generated by some companies are supporting diagnostic development.